View in EDS HTML Full Text PDF Full Text

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.

Saved in:
Bibliographic Details
Title: Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
Authors: Balcells, María Elvira1 (AUTHOR) ebalcells@uc.cl, Rojas, Luis2,3 (AUTHOR), Le Corre, Nicole4,5 (AUTHOR), Martínez-Valdebenito, Constanza4,5 (AUTHOR), Ceballos, María Elena1 (AUTHOR), Ferrés, Marcela4,5 (AUTHOR), Chang, Mayling6 (AUTHOR), Vizcaya, Cecilia4 (AUTHOR), Mondaca, Sebastián6 (AUTHOR), Huete, Álvaro7 (AUTHOR), Castro, Ricardo8 (AUTHOR), Sarmiento, Mauricio6 (AUTHOR), Villarroel, Luis9 (AUTHOR), Pizarro, Alejandra1 (AUTHOR), Ross, Patricio2 (AUTHOR), Santander, Jaime10 (AUTHOR), Lara, Bárbara11 (AUTHOR), Ferrada, Marcela12 (AUTHOR), Vargas-Salas, Sergio6 (AUTHOR), Beltrán-Pavez, Carolina13,14 (AUTHOR)
Source: PLoS Medicine. 3/3/2021, Vol. 17 Issue 3, p1-18. 18p. 1 Diagram, 2 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15491277
DOI:10.1371/journal.pmed.1003415